Aptevo Announces Proposed Public Offering of Common Stock and Warrants

    NEXT STORY
    Innovative Cellular Therapeutics Announces Opening of U.S. Office and Appointment of New Members to Executive Leadership Team
    PREV STORY
    Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FIT Biotech Oy: Tekes issues a decision on the company’s rectification request related to Tekes’s claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

    FIT BIOTECH OYCompany release October 24, 2016 at 17.15 pm EET      Tekes issues ...

    author_avatar
    NASDAQ Market News

    AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results

    ALBANY, N.Y., March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, ...

    author_avatar
    NASDAQ Market News

    AB Science announces that the European Academy of Allergy & Clinical Immunology (EAACI) 2020 Annual Congress has accepted its phase 3 study results with masitinib in severe asthma to be delivered as a late breaking oral presentation

    author_avatar
    NASDAQ Market News